Posts tagged pharma

Strategic Acquisition: A CEO's View - Pharmaceutical Executive

Richard Pops, Chief Executive Officer of Alkermes, explains how the company has established itself as a global, Irish-based firm.

Source: PharmExec

What Does the Future Hold for Biosimilars?

Biosimilars are “generic” biologics, which are medicines made of living organisms such as bacterium or yeast, and biosimilars are similar versions of biologics that were authorized before.

There are 63 billion $ of global biologic sale products due to come off patent by 2016. The biosimilars with their reduced costs have great potential.

Source: PharmaPhorum

Where Do Diagnostics Fit in Pharma Strategy?

In Vitro diagnostics are becoming more and more important. M&A activity is heating up, and so are issues regarding pricing, reimbursement and Rx-Dx partnerships.

Sourcs: PharmaPhorum

Perspective on Biotech: John Carroll of FierceBiotech

Insight about the biotech business: coping with the current economic climate, biotech activity in emerging markets, exciting biotech companies to watch and the future of the biotech industry.

Source: PharmaPhorum

The Stats About Pharmaceutical companies

The Stats About Pharmaceutical companies